BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 894525)

  • 1. Delay in nerve degeneration after sympathectomy of the submaxillary gland of the rat by treatment with pargyline, nialamide or beta-TM-10.
    Arbilla S; Perec CJ; Stefano FJ
    J Pharmacol Exp Ther; 1977 Sep; 202(3):622-34. PubMed ID: 894525
    [No Abstract]   [Full Text] [Related]  

  • 2. Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
    Arbilla S; Perec CJ; Stefano FJ
    Eur J Pharmacol; 1980 Jan; 61(2):147-57. PubMed ID: 7353586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in neuronal uptake and metabolism of, and sensitivity to, norepinephrine during the degeneration secretion in the rat submaxillary gland.
    Stefano FJ; Perec CJ; Tumilasci OR
    J Pharmacol Exp Ther; 1974 Dec; 191(3):403-17. PubMed ID: 4427287
    [No Abstract]   [Full Text] [Related]  

  • 4. Delay by drugs of adrenergic nerve degeneration after proximal or distal sympathectomy of the submaxillary gland.
    Sanz NR; Stefano FJ; Perec CJ
    Gen Pharmacol; 1982; 13(3):195-202. PubMed ID: 7095398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuronal and hormonal influences on the turnover of monoamine oxidase in salivary gland.
    Goridis C; Neff NH
    Biochem Pharmacol; 1973 Oct; 22(20):2501-10. PubMed ID: 4763586
    [No Abstract]   [Full Text] [Related]  

  • 7. Electron microscopic evidence that bretylium and pargyline delay adrenergic nerve degeneration after sympathectomy of the pineal gland.
    Sanz NR; Gomez-Dumm GL; Perec CJ; Stefano FJ
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):136-9. PubMed ID: 7110375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of degeneration of short and long postganglionic sympathetic nerve fibres and effect of pentobarbitone and colchicine on degeneration.
    Wakade AR
    Br J Pharmacol; 1978 Apr; 62(4):553-61. PubMed ID: 656699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline uptake mechanisms in the mouse atrium. A biochemical and histochemical study.
    Sachs C
    Acta Physiol Scand Suppl; 1970; 341():1-66. PubMed ID: 5452309
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bretylium on degeneration secretion of saliva.
    Emmelin N
    Experientia; 1972 Aug; 28(8):911. PubMed ID: 5076319
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 6-hydroxydopamine Treatment at birth on the submaxillary gland of the rat.
    Perec CJ; Stefano FJ; Baratti CM; Tumilasci OR
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):257-74. PubMed ID: 169485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    BartonĂ­cek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-lasting supersensitivity after 6-hydroxydopamine in the submaxillary gland of the rat.
    Perec CJ; Stefano FJ; Barrio Rendo ME
    J Pharmacol Exp Ther; 1973 Aug; 186(2):220-9. PubMed ID: 4719777
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of three monoamine oxidase inhibitors on ethanol preference in mice.
    Sanders B; Collins AC; Petersen DR; Fish BS
    Pharmacol Biochem Behav; 1977 Mar; 6(3):319-24. PubMed ID: 857255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of monoamine oxidase inhibitors on the disposition of intracisternally administered metaraminol-3H.
    Breese GR; Chase TN; Kopin IJ
    Biochem Pharmacol; 1970 Feb; 19(2):525-32. PubMed ID: 4396250
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence and properties of monoamine oxidase in adrenergic neurons.
    Jarrott B
    J Neurochem; 1971 Jan; 18(1):7-16. PubMed ID: 5550080
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of nialamide on the metabolism of dopamine injected into the nucleus accumbens of old rats.
    Cousin KM; Gerald MC; Uretsky NJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):25-30. PubMed ID: 3958967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in catechol-O-methyl transferase activity in the rat submaxillary gland after surgical and pharmacological procedures.
    Broch OJ; Guldberg HC; Marsden CA
    Br J Pharmacol; 1971 Feb; 41(2):393P-394P. PubMed ID: 5572293
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.